cardiovascular disease

(redirected from Cardiovascular disorders)
Also found in: Dictionary, Medical, Encyclopedia.
Related to Cardiovascular disorders: Cardiovascular diseases, Cardiac disease
  • noun

Words related to cardiovascular disease

References in periodicals archive ?
Fore Pharma's latest report Global Cardiovascular Disorders Drug Pipeline Capsule - 2012' provides up-to-date information on key research and development activities in the global cardiovascular disorders drug market.
Plasmid DNA-based delivery in cardiovascular disorders 82
a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that Lewis Rubin, M.
Aramed has contracted with Gensia to conduct research and development in three program areas: second generation ARAs for use in the intravenous treatment of acute cardiovascular disorders, ARAs for the oral and intravenous treatment of certain seizure disorders, and ARAs and adenosine agonists for the intravenous treatment of acute cerebrovascular disorders.
OTC BB: PYMX), an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, has received issuance of U.
This important agreement with Sterling Winthrop and Elf Sanofi will further strengthen our cardiovascular portfolio and provide some of the most advanced agents for prevalent cardiovascular disorders.
AVANIR's products and product candidates address therapeutic markets that include the central nervous system, cardiovascular disorders, inflammation and infectious diseases.
The worldwide strategic cooperative effort involves the joint development and commercialization of an Elf Sanofi angiotensin II receptor antagonist for the treatment of hypertension and possibly other cardiovascular disorders, and clopidogrel, a novel antithrombotic agent for potential prevention of heart attack, stroke and peripheral arterial disease, which is currently being developed by the Elf Sanofi/Sterling Winthrop alliance.
OTC BB: PYMX), an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, announced today that Nicholas Landekic, President and Chief Executive Officer, will present an overview and update on the company at the J.
Full browser ?